{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:07:47Z","timestamp":1788865667575,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20230452"],"award-info":[{"award-number":["BK20230452"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key projects of Traditional Chinese Medicine Technology Development Plan of Jiangsu Province","award":["ZD202201"],"award-info":[{"award-number":["ZD202201"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Saudi Pharm. J."],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s44446-026-00089-9","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T14:52:25Z","timestamp":1783954345000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Huachansu triggers mitochondrial apoptosis and ER stress to inhibit hepatocellular carcinoma progression"],"prefix":"10.1007","volume":"34","author":[{"given":"Ximeng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuying","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qibiao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghai","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changliang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyang","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiani","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengtao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixing","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongdong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"89_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-024-03349-4","author":"M AmeliMojarad","year":"2024","unstructured":"AmeliMojarad M, AmeliMojarad M, Shariati P (2024) Cinobufagin treatments suppress tumor growth by enhancing the expression of cuproptosis-related genes in liver cancer. Naunyn Schmiedebergs Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-024-03349-4","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"89_CR2","doi-asserted-by":"publisher","DOI":"10.1101\/pdb.prot065490","author":"B Chazotte","year":"2011","unstructured":"Chazotte B (2011) Labeling mitochondria with JC-1. Cold Spring Harb Protoc. https:\/\/doi.org\/10.1101\/pdb.prot065490","journal-title":"Cold Spring Harb Protoc"},{"key":"89_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2023.115875","volume":"239","author":"C Chen","year":"2024","unstructured":"Chen C, Wu H, Fu X, Li R, Cheng H, Wang M et al (2024) A UPLC-QTOF\/MS-based hepatic tissue metabolomics approach deciphers the mechanism of Huachansu tablets-based intervention against hepatocellular carcinoma. J Pharm Biomed Anal 239:115875. https:\/\/doi.org\/10.1016\/j.jpba.2023.115875","journal-title":"J Pharm Biomed Anal"},{"key":"89_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1159\/000545341","volume":"70","author":"YL Chen","year":"2025","unstructured":"Chen YL, Chou CW, Liu IH, Wu YH, Chen CY (2025) Endoplasmic reticulum stress modulates therapeutic responses in hepatocellular carcinoma. Chemotherapy 70:177\u2013192. https:\/\/doi.org\/10.1159\/000545341","journal-title":"Chemotherapy"},{"key":"89_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05460-9","volume":"22","author":"Z Cheng","year":"2024","unstructured":"Cheng Z, Li S, Yang S, Long H, Wu H, Chen X et al (2024) Endoplasmic reticulum stress promotes hepatocellular carcinoma by modulating immunity: a study based on artificial neural networks and single-cell sequencing. J Transl Med 22:658. https:\/\/doi.org\/10.1186\/s12967-024-05460-9","journal-title":"J Transl Med"},{"key":"89_CR6","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1093\/jpp\/rgad059","volume":"75","author":"CL Dai","year":"2023","unstructured":"Dai CL, Zhang RJ, An P, Deng YQ, Rahman K, Zhang H (2023) Cinobufagin: a promising therapeutic agent for cancer. J Pharm Pharmacol 75:1141\u20131153. https:\/\/doi.org\/10.1093\/jpp\/rgad059","journal-title":"J Pharm Pharmacol"},{"key":"89_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-021-04082-4","volume":"79","author":"L Daverkausen-Fischer","year":"2021","unstructured":"Daverkausen-Fischer L, Pr\u00f6ls F (2021) The function of the co-chaperone ERdj4 in diverse (patho-)physiological conditions. Cell Mol Life Sci 79:9. https:\/\/doi.org\/10.1007\/s00018-021-04082-4","journal-title":"Cell Mol Life Sci"},{"key":"89_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155169","volume":"123","author":"YQ Deng","year":"2024","unstructured":"Deng YQ, Gao M, Lu D, Liu QP, Zhang RJ, Ye J et al (2024) Compound-composed Chinese medicine of Huachansu triggers apoptosis of gastric cancer cells through increase of reactive oxygen species levels and suppression of proteasome activities. Phytomedicine 123:155169. https:\/\/doi.org\/10.1016\/j.phymed.2023.155169","journal-title":"Phytomedicine"},{"key":"89_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2024.171234","volume":"922","author":"J Du","year":"2024","unstructured":"Du J, Zhang X, Li B, Huo S, Zhang J, Fu Y et al (2024) The hepatotoxicity of hexafluoropropylene oxide trimer acid caused by apoptosis via endoplasmic reticulum-mitochondrial crosstalk. Sci Total Environ 922:171234. https:\/\/doi.org\/10.1016\/j.scitotenv.2024.171234","journal-title":"Sci Total Environ"},{"key":"89_CR10","doi-asserted-by":"publisher","first-page":"831","DOI":"10.18388\/abp.2020_6245","volume":"69","author":"W Feng","year":"2022","unstructured":"Feng W, Zhao X, Yao Q, Li D (2022) Cinobufagin inhibits proliferation and induces apoptosis of hepatocarcinoma cells by activating apoptosis, AKT, and ERK pathways. Acta Biochim Pol 69:831\u2013837. https:\/\/doi.org\/10.18388\/abp.2020_6245","journal-title":"Acta Biochim Pol"},{"key":"89_CR11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jbbm.2005.10.003","volume":"65","author":"A Gomes","year":"2005","unstructured":"Gomes A, Fernandes E, Lima JL (2005) Fluorescence probes used for detection of reactive oxygen species. J Biochem Biophys Methods 65:45\u201380. https:\/\/doi.org\/10.1016\/j.jbbm.2005.10.003","journal-title":"J Biochem Biophys Methods"},{"key":"89_CR12","doi-asserted-by":"publisher","unstructured":"Green MR, Sambrook J (2018) Analysis and normalization of real-time Polymerase Chain Reaction (PCR) experimental data. Cold Spring Harb Protoc 2018. https:\/\/doi.org\/10.1101\/pdb.top095000","DOI":"10.1101\/pdb.top095000"},{"key":"89_CR13","doi-asserted-by":"publisher","first-page":"23306","DOI":"10.18632\/oncotarget.4202","volume":"6","author":"L He","year":"2015","unstructured":"He L, Tian DA, Li PY, He XX (2015) Mouse models of liver cancer: progress and recommendations. Oncotarget 6:23306\u201323322. https:\/\/doi.org\/10.18632\/oncotarget.4202","journal-title":"Oncotarget"},{"key":"89_CR14","doi-asserted-by":"publisher","first-page":"2.1.1","DOI":"10.1002\/0471142735.im0201s110","volume":"110","author":"PV Hornbeck","year":"2015","unstructured":"Hornbeck PV (2015) Enzyme-linked immunosorbent assays. Curr Protoc Immunol 110:2.1.1-2.1.23. https:\/\/doi.org\/10.1002\/0471142735.im0201s110","journal-title":"Curr Protoc Immunol"},{"key":"89_CR15","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","volume":"18","author":"DQ Huang","year":"2021","unstructured":"Huang DQ, El-Serag HB, Loomba R (2021) Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 18:223\u2013238. https:\/\/doi.org\/10.1038\/s41575-020-00381-6","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"89_CR16","doi-asserted-by":"publisher","first-page":"408","DOI":"10.2174\/1574892817666220511162046","volume":"18","author":"CY Huang","year":"2023","unstructured":"Huang CY, Cheng YM, Li W, Huang YC, Luo H, Zhong C et al (2023) Examining the mechanisms of Huachansu injection on liver cancer through integrated bioinformatics analysis. Recent Pat Anticancer Drug Discov 18:408\u2013425. https:\/\/doi.org\/10.2174\/1574892817666220511162046","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"89_CR17","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/978-1-0716-2780-8_26","volume":"2588","author":"HM Hussaini","year":"2023","unstructured":"Hussaini HM, Seo B, Rich AM (2023) Immunohistochemistry and immunofluorescence. Methods Mol Biol 2588:439\u2013450. https:\/\/doi.org\/10.1007\/978-1-0716-2780-8_26","journal-title":"Methods Mol Biol"},{"key":"89_CR18","doi-asserted-by":"publisher","unstructured":"Khaled J, Kopsida M, Lennern\u00e4s H, Heindryckx F (2022) Drug resistance and endoplasmic reticulum stress in hepatocellular carcinoma. Cells 11. https:\/\/doi.org\/10.3390\/cells11040632","DOI":"10.3390\/cells11040632"},{"key":"89_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2024.102406","volume":"15","author":"A Koshy","year":"2025","unstructured":"Koshy A (2025) Evolving global etiology of hepatocellular carcinoma (HCC): insights and trends for 2024. J Clin Exp Hepatol 15:102406. https:\/\/doi.org\/10.1016\/j.jceh.2024.102406","journal-title":"J Clin Exp Hepatol"},{"key":"89_CR20","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1208\/s12248-016-9924-z","volume":"18","author":"G Lestini","year":"2016","unstructured":"Lestini G, Mentr\u00e9 F, Magni P (2016) Optimal design for informative protocols in xenograft tumor growth inhibition experiments in mice. AAPS J 18:1233\u20131243. https:\/\/doi.org\/10.1208\/s12248-016-9924-z","journal-title":"AAPS J"},{"key":"89_CR21","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ebiom.2018.11.063","volume":"39","author":"B Li","year":"2019","unstructured":"Li B, Cao Y, Meng G, Qian L, Xu T, Yan C et al (2019a) Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt\/beta-catenin pathway. EBioMedicine 39:239\u2013254. https:\/\/doi.org\/10.1016\/j.ebiom.2018.11.063","journal-title":"EBioMedicine"},{"key":"89_CR22","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41419-019-1918-1","volume":"10","author":"D Li","year":"2019","unstructured":"Li D, Wang WJ, Wang YZ, Wang YB, Li YL (2019b) Lobaplatin promotes (125)I-induced apoptosis and inhibition of proliferation in hepatocellular carcinoma by upregulating PERK-eIF2\u03b1-ATF4-CHOP pathway. Cell Death Dis 10:744. https:\/\/doi.org\/10.1038\/s41419-019-1918-1","journal-title":"Cell Death Dis"},{"key":"89_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1399882","volume":"15","author":"Y Liao","year":"2024","unstructured":"Liao Y, Wei F, He Z, He J, Ai Y, Guo C et al (2024) Animal-derived natural products for hepatocellular carcinoma therapy: current evidence and future perspectives. Front Pharmacol 15:1399882. https:\/\/doi.org\/10.3389\/fphar.2024.1399882","journal-title":"Front Pharmacol"},{"key":"89_CR24","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/s41420-024-01911-w","volume":"10","author":"YS Lin","year":"2024","unstructured":"Lin YS, Sun Z, Shen LS, Gong RH, Chen JW, Xu Y et al (2024) Arnicolide D induces endoplasmic reticulum stress-mediated oncosis via ATF4 and CHOP in hepatocellular carcinoma cells. Cell Death Discov 10:134. https:\/\/doi.org\/10.1038\/s41420-024-01911-w","journal-title":"Cell Death Discov"},{"key":"89_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115740","volume":"215","author":"T Luangmonkong","year":"2023","unstructured":"Luangmonkong T, Parichatikanond W, Olinga P (2023) Targeting collagen homeostasis for the treatment of liver fibrosis: opportunities and challenges. Biochem Pharmacol 215:115740. https:\/\/doi.org\/10.1016\/j.bcp.2023.115740","journal-title":"Biochem Pharmacol"},{"key":"89_CR26","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/j.ajpath.2022.09.012","volume":"193","author":"C Luna-Marco","year":"2023","unstructured":"Luna-Marco C, Ubink A, Kopsida M, Heindryckx F (2023) Endoplasmic reticulum stress and metabolism in hepatocellular carcinoma. Am J Pathol 193:1377\u20131388. https:\/\/doi.org\/10.1016\/j.ajpath.2022.09.012","journal-title":"Am J Pathol"},{"key":"89_CR27","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1007\/s11033-018-4258-9","volume":"45","author":"P Majtnerov\u00e1","year":"2018","unstructured":"Majtnerov\u00e1 P, Rou\u0161ar T (2018) An overview of apoptosis assays detecting DNA fragmentation. Mol Biol Rep 45:1469\u20131478. https:\/\/doi.org\/10.1007\/s11033-018-4258-9","journal-title":"Mol Biol Rep"},{"key":"89_CR28","doi-asserted-by":"publisher","first-page":"5309","DOI":"10.1002\/cncr.24602","volume":"115","author":"Z Meng","year":"2009","unstructured":"Meng Z, Yang P, Shen Y, Bei W, Zhang Y, Ge Y et al (2009) Pilot study of Huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer. Cancer 115:5309\u20135318. https:\/\/doi.org\/10.1002\/cncr.24602","journal-title":"Cancer"},{"key":"89_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2024.189164","volume":"1879","author":"X Peng","year":"2024","unstructured":"Peng X, He Z, Yuan D, Liu Z, Rong P (2024) Lactic acid: the culprit behind the immunosuppressive microenvironment in hepatocellular carcinoma. Biochim Biophys Acta Rev Cancer 1879:189164. https:\/\/doi.org\/10.1016\/j.bbcan.2024.189164","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"89_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2020.113608","volume":"593","author":"L Pillai-Kastoori","year":"2020","unstructured":"Pillai-Kastoori L, Schutz-Geschwender AR, Harford JA (2020) A systematic approach to quantitative Western blot analysis. Anal Biochem 593:113608. https:\/\/doi.org\/10.1016\/j.ab.2020.113608","journal-title":"Anal Biochem"},{"key":"89_CR31","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1080\/14712598.2024.2363234","volume":"24","author":"F Rossari","year":"2024","unstructured":"Rossari F, Foti S, Camera S, Persano M, Casadei-Gardini A, Rimini M (2024) Treatment options for advanced hepatocellular carcinoma: the potential of biologics. Expert Opin Biol Ther 24:455\u2013470. https:\/\/doi.org\/10.1080\/14712598.2024.2363234","journal-title":"Expert Opin Biol Ther"},{"key":"89_CR32","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2174\/1566524016666160523143937","volume":"16","author":"W Rozpedek","year":"2016","unstructured":"Rozpedek W, Pytel D, Mucha B, Leszczynska H, Diehl JA, Majsterek I (2016) The role of the PERK\/eIF2\u03b1\/ATF4\/CHOP signaling pathway in tumor progression during endoplasmic reticulum stress. Curr Mol Med 16:533\u2013544. https:\/\/doi.org\/10.2174\/1566524016666160523143937","journal-title":"Curr Mol Med"},{"key":"89_CR33","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","volume":"77","author":"H Rumgay","year":"2022","unstructured":"Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag CJ, Vignat J et al (2022) Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol 77:1598\u20131606. https:\/\/doi.org\/10.1016\/j.jhep.2022.08.021","journal-title":"J Hepatol"},{"key":"89_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2024.102446","volume":"15","author":"SP Singh","year":"2025","unstructured":"Singh SP, Madke T, Chand P (2025) Global epidemiology of hepatocellular carcinoma. J Clin Exp Hepatol 15:102446. https:\/\/doi.org\/10.1016\/j.jceh.2024.102446","journal-title":"J Clin Exp Hepatol"},{"key":"89_CR35","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.11200","volume":"9","author":"Z Tang","year":"2021","unstructured":"Tang Z, He J, Zou J, Yu S, Sun X, Qin L (2021) Cisplatin-resistant HepG2 cell-derived exosomes transfer cisplatin resistance to cisplatin-sensitive cells in HCC. PeerJ 9:e11200. https:\/\/doi.org\/10.7717\/peerj.11200","journal-title":"PeerJ"},{"key":"89_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e24395","volume":"10","author":"D Tang","year":"2024","unstructured":"Tang D, Feng Y, Lu J, Jia L, Shen D, Shang J et al (2024) Global trends in bufalin application research for cancer from 2003 to 2022: a bibliometric and visualised analysis. Heliyon 10:e24395. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e24395","journal-title":"Heliyon"},{"key":"89_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-81481-0","volume":"14","author":"X Wang","year":"2024","unstructured":"Wang X, Li P, Ji H, Xu Z, Xing H (2024) Single-cell transcriptomics reveals over-activated reactive oxygen species pathway in hepatocytes in the development of hepatocellular carcinoma. Sci Rep 14:29809. https:\/\/doi.org\/10.1038\/s41598-024-81481-0","journal-title":"Sci Rep"},{"key":"89_CR38","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1053\/j.semdp.2019.06.003","volume":"36","author":"MR Wick","year":"2019","unstructured":"Wick MR (2019) The hematoxylin and eosin stain in anatomic pathology-an often-neglected focus of quality assurance in the laboratory. Semin Diagn Pathol 36:303\u2013311. https:\/\/doi.org\/10.1053\/j.semdp.2019.06.003","journal-title":"Semin Diagn Pathol"},{"key":"89_CR39","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3350\/cmh.2022.0402","volume":"29","author":"D Xie","year":"2023","unstructured":"Xie D, Shi J, Zhou J, Fan J, Gao Q (2023) Clinical practice guidelines and real-life practice in hepatocellular carcinoma: a Chinese perspective. Clin Mol Hepatol 29:206\u2013216. https:\/\/doi.org\/10.3350\/cmh.2022.0402","journal-title":"Clin Mol Hepatol"},{"key":"89_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202304476","volume":"13","author":"T Xie","year":"2024","unstructured":"Xie T, Huang C, Wang Y, Zhang H, Guo P, Phann TT et al (2024) An \u201call-in-one\u201d immunomodulator-engineered clinical translatable immunotherapy of advanced hepatocellular carcinoma. Adv Healthc Mater 13:e2304476. https:\/\/doi.org\/10.1002\/adhm.202304476","journal-title":"Adv Healthc Mater"},{"key":"89_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2023.109699","volume":"744","author":"L Xing","year":"2023","unstructured":"Xing L, Tang Y, Li L, Tao X (2023) ROS in hepatocellular carcinoma: what we know. Arch Biochem Biophys 744:109699. https:\/\/doi.org\/10.1016\/j.abb.2023.109699","journal-title":"Arch Biochem Biophys"},{"key":"89_CR42","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1142\/s0192415x23500726","volume":"51","author":"Z Xu","year":"2023","unstructured":"Xu Z, Bao J, Jin X, Li H, Fan K, Wu Z et al (2023) The effects of Cinobufagin on hepatocellular carcinoma cells enhanced by MRT68921, an autophagy inhibitor. Am J Chin Med 51:1595\u20131611. https:\/\/doi.org\/10.1142\/s0192415x23500726","journal-title":"Am J Chin Med"},{"key":"89_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2021.115739","volume":"431","author":"AL Yang","year":"2021","unstructured":"Yang AL, Wu Q, Hu ZD, Wang SP, Tao YF, Wang AM et al (2021) A network pharmacology approach to investigate the anticancer mechanism of cinobufagin against hepatocellular carcinoma via downregulation of EGFR-CDK2 signaling. Toxicol Appl Pharmacol 431:115739. https:\/\/doi.org\/10.1016\/j.taap.2021.115739","journal-title":"Toxicol Appl Pharmacol"},{"key":"89_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2022.109938","volume":"360","author":"A Yang","year":"2022","unstructured":"Yang A, Wu Q, Chen Q, Yang J, Li H, Tao Y et al (2022) Cinobufagin restrains the growth and triggers DNA damage of human hepatocellular carcinoma cells via proteasome-dependent degradation of thymidylate synthase. Chem Biol Interact 360:109938. https:\/\/doi.org\/10.1016\/j.cbi.2022.109938","journal-title":"Chem Biol Interact"},{"key":"89_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2022.106229","volume":"130","author":"A Yang","year":"2023","unstructured":"Yang A, Wu Q, Wang A, Chen Q, Yang J, Tao Y et al (2023) Integrated transcriptomics and metabolomics analyses to investigate the anticancer mechanisms of cinobufagin against liver cancer through interfering with lipid, amino acid, carbohydrate, and nucleotide metabolism. Bioorg Chem 130:106229. https:\/\/doi.org\/10.1016\/j.bioorg.2022.106229","journal-title":"Bioorg Chem"},{"key":"89_CR46","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ccell.2024.01.007","volume":"42","author":"X Yang","year":"2024","unstructured":"Yang X, Yang C, Zhang S, Geng H, Zhu AX, Bernards R et al (2024) Precision treatment in advanced hepatocellular carcinoma. Cancer Cell 42:180\u2013197. https:\/\/doi.org\/10.1016\/j.ccell.2024.01.007","journal-title":"Cancer Cell"},{"key":"89_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2019.112178","volume":"246","author":"X Zhan","year":"2020","unstructured":"Zhan X, Wu H, Wu H, Wang R, Luo C, Gao B et al (2020) Metabolites from Bufo gargarizans (Cantor, 1842): a review of traditional uses, pharmacological activity, toxicity and quality control. J Ethnopharmacol 246:112178. https:\/\/doi.org\/10.1016\/j.jep.2019.112178","journal-title":"J Ethnopharmacol"},{"key":"89_CR48","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s12672-024-01377-3","volume":"15","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Tian Y, Wang Z, Zhang Y, Wang G (2024) Bibliometric analysis of endoplasmic reticulum stress in hepatocellular carcinoma: trends and future directions. Discov Oncol 15:481. https:\/\/doi.org\/10.1007\/s12672-024-01377-3","journal-title":"Discov Oncol"}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44446-026-00089-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44446-026-00089-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44446-026-00089-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:17:29Z","timestamp":1788862649000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44446-026-00089-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["89"],"URL":"https:\/\/doi.org\/10.1007\/s44446-026-00089-9","relation":{},"ISSN":["1319-0164","2213-7475"],"issn-type":[{"value":"1319-0164","type":"print"},{"value":"2213-7475","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"21 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experimental protocols were approved by the Animal Ethics Committee of Nanjing University of Chinese Medicine (Approval No.: 202501A039), and the study adhered to international ethical guidelines for animal research, ensuring minimal pain and distress.","order":1,"name":"Ethics","label":"Ethical","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"42"}}